Skip to main content
Key Specialties
Anesthesiology Cardiology Dermatology Diabetology Endocrinology Gastroenterology General Medicine Geriatrics Hematology Infectious Diseases Internal Medicine Nephrology Neurology Obstetrics and Gynecology Oncology Pediatrics Psychiatry Radiology Respiratory Medicine Rheumatology Surgery Urology
Congress Coverage
2024 ESMO Congress 2024 ERS Congress 2024 EASD Congress 2024 ESC Congress 2024 EAN Congress 2024 ASCO Annual Meeting 2024 ACC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on modern management of frailty

LIVE: Thursday 17th October 2024, 18:00-19:30 (CEST)

Frailty has a significant impact on health and wellbeing, especially in older adults. Join our experts to understand the factors that contribute to the development of frailty and find out how to manage the condition and reduce the risk of disability, dependency, and mortality.
ADVANCED SEARCH
Log in
Top
International Journal of Behavioral Medicine

06-09-2024 | Vulgar Psoriasis | Integrative Review

Effect of Psychological Intervention on Quality of Life Among Patients with Psoriasis: A Meta-analysis

Authors: Wenju Wei, Bei Zhang, Tian Liu, Tao Lu

Published in: International Journal of Behavioral Medicine

Login to get access

Abstract

Background

Psychological distress can significantly obstruct the treatment outcomes of patients with psoriasis. This meta-analysis aimed to examine the effects of psychological intervention on the mental health and functional capabilities in patients with psoriasis.

Method

PubMed, EMBASE, and Cochrane Library were searched for relevant studies published up to May 1, 2023. The primary outcome was a change in anxiety, depression, and quality of life (QoL). Standardized mean difference (SMD) was calculated, and 95% confidence interval (CI) was determined for the estimation.

Results

This meta-analysis involved 1048 subjects, including 515 patients who received psychological interventions and 533 patients in control groups who did not receive psychological interventions. The results showed that psychological intervention significantly improved anxiety symptoms (SMD − 0.41; 95%CI − 0.77, − 0.05; I2 = 71.5%; PHeterogeneity = 0 .001). There was no significant improvement in the symptoms of depression (SMD − 0.52; 95%CI − 1.13, 0.10; I2 = 86%; PHeterogeneity < 0 .001) and QoL (SMD − 0.05; 95%CI − 0.22, 0.11; I2 = 39%; PHeterogeneity = 0 .108) in patients who received psychological intervention compared with controls.

Conclusion

Psychological intervention ameliorated anxiety symptoms in patients with psoriasis but had no significant impact on depression or QoL.
Appendix
Available only for authorised users
Literature
1.
Iskandar I, Parisi R, Griffiths C, Ashcroft D, Atlas GP. Systematic review examining changes over time and variation in the incidence and prevalence of psoriasis by age and gender. Br J Dermatol. 2021;184:243–58.PubMedCrossRef
2.
Kimmel GW, Lebwohl M. Psoriasis: Overview and Diagnosis. In: Evidence-Based Psoriasis. Springer. 2018:1–16
3.
Damiani G, Cazzaniga S, Conic RR, et al. Pruritus characteristics in a large Italian cohort of psoriatic patients. J Eur Acad Dermatol Venereol. 2019;33:1316–24.PubMedPubMedCentralCrossRef
4.
Brandon A, Mufti A, Sibbald RG. Diagnosis and management of cutaneous psoriasis: a review. Adv Skin Wound Care. 2019;32:58–69.PubMedCrossRef
5.
Gisondi P, Talamonti M, Chiricozzi A, et al. Treat-to-target approach for the management of patients with moderate-to-severe plaque psoriasis: consensus recommendations. Dermatol Ther. 2021;11:235–52.CrossRef
6.
McCullough PJ, McCullough WP, Lehrer D, et al. Oral and topical vitamin D, sunshine, and UVB phototherapy safely control psoriasis in patients with normal pretreatment serum 25-hydroxyvitamin d concentrations: a literature review and discussion of health implications. Nutrients. 2021;13:1511–44.PubMedPubMedCentralCrossRef
7.
Kennedy R. Phototherapy as a treatment for dermatological diseases, cancer, aesthetic dermatologic conditions and allergenic rhinitis in adult and paediatric medicine. Life (Basel). 2023;13:196.PubMedPubMedCentral
8.
Marek-Jozefowicz L, Czajkowski R, Borkowska A, et al. The brain–skin axis in psoriasis—psychological, psychiatric, hormonal, and dermatological aspects. Int J Mol Sci. 2022;23:669.PubMedPubMedCentralCrossRef
9.
Woźniak E, Owczarczyk-Saczonek A, Placek W. Psychological stress, mast cells, and psoriasis—is there any relationship? Int J Mol Sci. 2021;22:13252.PubMedPubMedCentralCrossRef
10.
11.
12.
Alesci A, Lauriano ER, Fumia A, et al. Relationship between immune cells, depression, stress, and psoriasis: could the use of natural products be helpful? Molecules. 2022;27:1953.PubMedPubMedCentralCrossRef
13.
Blackstone B, Patel R, Bewley A. Assessing and improving psychological well-being in psoriasis: considerations for the clinician. Psoriasis: Targets Ther. 2022;12:25–33.CrossRef
14.
Olivier C, Robert PD, Daihung D, et al. The risk of depression, anxiety, and suicidality in patients with psoriasis: a population-based cohort study. Arch Dermatol. 2010;146:891–5.CrossRef
15.
Shen M, Cao D, Xiao Y, et al. Serum 5-hydroxytryptamine is related to psoriasis severity in patients with comorbid anxiety or depression. Acta Derm Venereol. 2021;101:adv00514.PubMedCrossRef
16.
Bakar RS, Jaapar SZ, Azmi AF, Aun YC. Depression and anxiety among patients with psoriasis: a correlation with quality of life and associated factors. J Taibah Univ Med Sci. 2021;16:491–6.PubMedPubMedCentral
17.
Esposito M, Saraceno R, Giunta A, Maccarone M, Chimenti SJD. An Italian study on psoriasis and depression. Dermatology. 2006;212:123–7.PubMedCrossRef
18.
Singh S, Taylor C, Kornmehl H, Armstrong AW. Psoriasis and suicidality: a systematic review and meta-analysis. J Am Acad Dermatol. 2017;77(425–440): e422.
19.
Lada G, Chinoy H, Heal C, et al. Depression and suicidality in patients with psoriasis and the role of psoriatic arthritis; a cross-sectional study in a tertiary setting. J Acad Consult-Liaison Psychiatry. 2022;S2667–2960(2621):00201–9.
20.
Price M, Mottahedin I, Mayo P. Can psychotherapy help patients with psoriasis? Clin Exp Dermatol. 1991;16:114–7.PubMedCrossRef
21.
Fortune D, Richards H, Kirby B, et al. A cognitive-behavioural symptom management programme as an adjunct in psoriasis therapy. Br J Dermatol. 2002;146:458–65.PubMedCrossRef
22.
Vedhara K, Morris RM, Booth R, et al. Changes in mood predict disease activity and quality of life in patients with psoriasis following emotional disclosure. J Psychosom Res. 2007;62:611–9.PubMedCrossRef
23.
Ersser S, Cowdell F, Nicholls P, Latter S, Healy E. A pilot randomized controlled trial to examine the feasibility and efficacy of an educational nursing intervention to improve self-management practices in patients with mild-moderate psoriasis. J Eur Acad Dermatol Venereol. 2012;26:738–45.PubMedCrossRef
24.
Bundy C, Pinder B, Bucci S, et al. A novel, web-based, psychological intervention for people with psoriasis: the electronic T argeted I ntervention for P soriasis (e TIP s) study. Br J Dermatol. 2013;169:329–36.PubMedCrossRef
25.
Schmitt J, Wozel G, Garzarolli M, et al. Effectiveness of interdisciplinary vs. dermatological care of moderate-to-severe psoriasis: a pragmatic randomised controlled trial. Acta Derm Venereol. 2014;94:192–7.PubMedCrossRef
26.
Fordham B, Griffiths C, Bundy C. A pilot study examining mindfulness-based cognitive therapy in psoriasis. Psychol Health Med. 2015;20(121):127.
27.
Larsen MH, Wahl AK, Krogstad A-L, Aas E. Cost-utility analysis of supported self-management with motivational interviewing for patients with psoriasis. Acta Derm Venereol. 2016;96:664–8.PubMedCrossRef
28.
Piaserico S, Marinello E, Dessi A, et al. Efficacy of biofeedback and cognitive-behavioural therapy in psoriatic patients. A single-blind, randomized and controlled study with added narrow-band ultraviolet B therapy. Acta Derm Venereol. 2016;96:91–5.PubMed
29.
van Beugen S, Ferwerda M, Spillekom-van Koulil S, et al. Tailored therapist-guided internet-based cognitive behavioral treatment for psoriasis: a randomized controlled trial. Psychother Psychosom. 2016;85:297–307.PubMedCrossRef
30.
Singh SM, Narang T, Vinay K, et al. Clinic-based group multi-professional education causes significant decline in psoriasis severity: a randomized open label pilot study. Indian Dermatol Online J. 2017;8:454.PubMedPubMedCentralCrossRef
31.
D’Alton P, Kinsella L, Walsh O, et al. Mindfulness-based interventions for psoriasis: a randomized controlled trial. Mindfulness. 2019;10:288–300.CrossRef
32.
Lakuta P. Brief self-affirmation intervention for adults with psoriasis for reducing anxiety and depression and boosting well-being: evidence from a randomized controlled trial. Psychol Med. 2021;53:2574–84.PubMedPubMedCentralCrossRef
33.
Dewi DAR, Wijayanti FA, Chen S, Firmansyah RSP. Cognitive behavioral therapy as an adjunctive treatment for anxiety and depression in psoriasis patients. Devotion: J Res Commun Service. 2023;4:1234–41.CrossRef
34.
Reibel DK, Greeson JM, Brainard GC, et al. Mindfulness-based stress reduction and health-related quality of life in a heterogeneous patient population. Gen Hosp Psychiatry. 2001;23:183–92.PubMedCrossRef
35.
Zachariae R, Øster H, Bjerring P, Kragballe K. Effects of psychologic intervention on psoriasis: a preliminary report. J Am Acad Dermatol. 1996;34:1008–15.PubMedCrossRef
36.
37.
38.
39.
Fortune DG, Richards HL, Kirby B, et al. Psychological distress impairs clearance of psoriasis in patients treated with photochemotherapy. Arch Dermatol. 2003;139:752–6.PubMedCrossRef
40.
Fjorback LO, Arendt M, Ørnbøl E, Fink P, Walach H. Mindfulness-based stress reduction and mindfulness-based cognitive therapy–a systematic review of randomized controlled trials. Acta Psychiatr Scand. 2011;124:102–19.PubMedCrossRef
41.
Tohid H, Aleem D, Jackson C. Major depression and psoriasis: a psychodermatological phenomenon. Skin Pharmacol Physiol. 2016;29:220–30.PubMedCrossRef
42.
Rosenblat JD, Cha DS, Mansur RB, McIntyre RS. Inflamed moods: a review of the interactions between inflammation and mood disorders. Prog Neuropsychopharmacol Biol Psychiatry. 2014;53:23–34.PubMedCrossRef
43.
Liu L, Lin NX, Yu YT, et al. Epidemiology of mental health comorbidity in patients with psoriasis: an analysis of trends from 1986 to 2019. Psychiatry Res. 2023;321: 115078.PubMedCrossRef
44.
Veenhoven R. Quality of life (QOL), an overview. In: Encyclopedia of Quality of Life and Well-Being Research. Springer. 2024:5668–5671.
45.
Schalock RL. The concept of quality of life: what we know and do not know. J Intellect Disabil Res. 2004;48:203–16.PubMedCrossRef
Metadata
Title
Effect of Psychological Intervention on Quality of Life Among Patients with Psoriasis: A Meta-analysis
Authors
Wenju Wei
Bei Zhang
Tian Liu
Tao Lu
Publication date
06-09-2024
Publisher
Springer US
Published in
International Journal of Behavioral Medicine
Print ISSN: 1070-5503
Electronic ISSN: 1532-7558
DOI
https://doi.org/10.1007/s12529-024-10315-0